Longeveron Exceeds 50% Enrollment in Lomecel-B™ Study for Hypoplastic Left Heart Syndrome

Company Activates Additional Study Location to Expedite Enrollment Completion HLHS is a congenital birth defect in which the left ventricle (one of the pu...

August 14, 2023 | Monday | News
Piramal Pharma Reports Strong Start to Financial Year with Revenue Surge and Promising Growth Prospects Across Business Segments, Says Chairperson Nandini Piramal

Nandini Piramal, Chairperson, Piramal Pharma Limited said, "We had a positive start to the new financial year with healthy revenue growth and improvem...

August 04, 2023 | Friday | News
Syneos Health Stockholders Approve Agreement with Private Investment Consortium

Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical solutions organ...

August 03, 2023 | Thursday | News
SomaLogic to Announce Second Quarter 2023 Financial Results on August 14, 2023

Those interested in listening to the conference call should register online here. Participants are encouraged to register more than 15 minutes before the s...

July 25, 2023 | Tuesday | News
Examining the Biopharma Industry's Declining Resilience: Factors, Vulnerabilities, and Strategies for Growth

Join us for an in-depth conversation with Chua Keng Hock as we explore the challenges, strategies, and future prospects of the biopharma industry in today'...

July 18, 2023 | Tuesday | Interaction
Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023

Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance. A liv...

July 14, 2023 | Friday | News
IQVIA to Announce Second-Quarter 2023 Results on August 1, 2023

To listen to the event and view the presentation slides via webcast, join from the IQVIA Investor Relations website at http://ir.iqvia.com. To participate ...

July 07, 2023 | Friday | News
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 26, 2023

During the call, the company will discuss its financial performance, as well as future expectations. To listen, call (833) 470-1428 within the U.S. or (404...

July 06, 2023 | Thursday | News
Camena Bioscience Raises $10M in Series A Funding Amid Growing DNA Synthesis Demand

Funding will be used to scale operations and continue development of its pioneering DNA synthesis platform, gSynth™ Funding round led by Mercia C...

July 04, 2023 | Tuesday | News
Abcam Highlights Successful Execution of Strategic Priorities to Drive Shareholder Value

Under CEO Alan Hirzel’s leadership, Abcam has transformed as a business, created significant value for all stakeholders, and outperformed the m...

June 21, 2023 | Wednesday | News
Danaher Schedules Second Quarter 2023 Earnings Conference Call

The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Eve...

June 21, 2023 | Wednesday | News
Philips to repurchase up to 7.1 million shares to cover long-term incentive plans

The repurchases will be executed through one or more individual forward transactions, expected to be entered into in the second and/or the third quarter of...

June 15, 2023 | Thursday | News
Biogen Announces Changes to Its Board of Directors

- Biogen Inc. (Nasdaq: BIIB) announced several changes to its Board of Directors . The changes will refresh the composition of the Board and follow th...

June 13, 2023 | Tuesday | News
Labcorp Announces Information in Connection with its Spin-off of Fortrea

The record date will be 5 p.m. Burlington, North Carolina time on Tuesday, June 20, 2023, and The distribution date will be 11:59 p.m. Burlington, North...

June 12, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in